Evidence map›Paper›PMID 26009197›Full record

ReviewBiochemical Society transactions2015

Emerging concepts regarding pannexin 1 in the vasculature.

Miranda E Good, Daniela Begandt, Leon J DeLalio, Alexander S Keller, Marie Billaud, Brant E Isakson

Abstract readReview
In one paragraph

Review in Biochemical Society transactions, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Impact of Estrogen on Purinergic Signaling in Microvascular Disease.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Pharmacology of pannexin channels.Current opinion in pharmacology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Pannexin-1 in Human Lymphatic Endothelial Cells Regulates Lymphangiogenesis.International journal of molecular sciences · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Osteoarthritis is what the people have.Journal of molecular medicine (Berlin, Germany) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Miranda E Good*Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, U.S.A.
Daniela Begandt*Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, U.S.A.
Leon J DeLalio*Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, U.S.A.
Alexander S Keller*Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, U.S.A.
Marie Billaud‡Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, U.S.A.
Brant E Isakson*Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, U.S.A.
University of Virginia · USUniversity of Pittsburgh · US

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A. · 2014 to 2023
$24.0M
BASIC CARDIOVASCULAR RESEARCH TRAINING GRANTT32HL007284 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Brant E Isakson, Gary K Owens · 1985 to 2026
$19.6M
Mechanisms of Heterocellular Signaling at the Myoenothelial JunctionR01HL088554 · NHLBI · UNIVERSITY OF VIRGINIA · PI ISAKSON, BRANT E, WEISS, MITCHELL J · 2008 to 2017
$3.8M
Pannexin 1 Channels in Cerebral Arterial Myogenic RegulationF32HL131399 · NHLBI · UNIVERSITY OF VIRGINIA · PI GOOD, MIRANDA E · 2016 to 2017
$71k
NHLBI NIH HHS F32 HL131399NHLBI NIH HHS HL007284NHLBI NIH HHS HL088554NHLBI NIH HHS HL120840NHLBI NIH HHS P01 HL120840NHLBI NIH HHS R01 HL088554NHLBI NIH HHS T32 HL007284
6 · The paper itself

Abstract

Pannexin channels are newly discovered ATP release channels expressed throughout the body. Pannexin 1 (Panx1) channels have become of great interest as they appear to participate in a multitude of signalling cascades, including regulation of vascular function. Although numerous Panx1 pharmacological inhibitors have been discovered, these inhibitors are not specific for Panx1 and have additional effects on other proteins. Therefore, molecular tools, such as RNA interference and knockout animals, are needed to demonstrate the role of pannexins in various cellular functions. This review focuses on the known roles of Panx1 related to purinergic signalling in the vasculature focusing on post-translational modifications and channel gating mechanisms that may participate in the regulated release of ATP.

Indexed as

Adenosine TriphosphateAnimalsConnexinsHumansMuscle, Smooth, VascularNerve Tissue ProteinsProtein Processing, Post-TranslationalReceptors, PurinergicRNA InterferenceSignal TransductionAdenosine TriphosphateConnexinsNerve Tissue ProteinsPANX1 protein, humanReceptors, Purinergic

Identifiers

PMID26009197
PMCPMC4824043
OpenAlexW2337801345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.